JNC: Prognostic value of [99m]technetium-pyrophosphate single-photon emission computed tomography visual grade in patients with transthyretin cardiac amyloidosis on stabilization therapy (Q3_25)
Course Overview

This Journal CME activity will review Prognostic value of 99mtechnetium-pyrophosphate single-photon emission computed tomography visual grade in patients with transthyretin cardiac amyloidosis on stabilization therapy.

Target Audience
This activity is targeted at imaging professionals and is intended to provide the latest information on clinical practice and cutting-edge scientific advances in nuclear cardiology and cardiac imaging.
Learner Objectives

After reading and reflecting upon this article in the Journal Nuclear Cardiology, the learner should be able to:

  1. Apply the non-invasive diagnostic pathway for ATTR-CM based on SPECT with bone-avid radiotracers.
  2. Understand the prognostic role of myocardial uptake on bone-avid radiotracer SPECT in patients on stabilization therapy for ATTR-CM.
  3. Identify prognostic metrics and scores associated with adverse outcomes in ATTR-CM .
Overall Goal
The purpose of this CME activity in the Journal of Nuclear Cardiology is to increase the learners’ competence in the application of nuclear cardiology strategies in clinical practice.
Accreditation and Continuing Education Credit
Evaluation Deadlines: AMA PRA Category 1 Credits™, ARRT Category A, and Participation Credits = September 16, 2026

The American Society of Nuclear Cardiology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.



Physicians: The American Society of Nuclear Cardiology designates this Journal-based CME activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Technologists: The American Society of Nuclear Cardiology is a recognized provider of continuing education credit for technologists. ASNC’s Continuing Education (CE) credit is accepted by both NMTCB and ARRT. This Journal-based activity has been approved for a maximum of 1 ARRT Category A credit for Technologists.
Continuing Education Term of Approval

Release Date:  September 17, 2025
Expiration Date: September 16, 2026

Processing Fees
ASNC members may claim continuing education credits at no charge. Non-members will be charged $50 per activity.
Summary
Availability:
On-Demand
Release on Sep 17, 2025 12:00 AM Central Daylight Time
Access expires on Sep 16, 2026
Cost:
Physician & Scientist: $0.00
International Emerging Markets: $0.00
International Physician & Scientist: $0.00
Trainee: $0.00
Non-Physician (Member): $0.00
Physician (Non-Member): $50.00
Non-Physician (Non-Member): $50.00
Credit Offered:
1 CME Credit
1 CE Credit
1 COP Credit
Powered By